Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by Stocktreeon Mar 15, 2016 9:31am
82 Views
Post# 24659040

RE:RE:RE:RE:RE:RE:RE:RE:RE:Marketing

RE:RE:RE:RE:RE:RE:RE:RE:RE:Marketing Yes, but isn't the opportunity significantly reduced if the company sets low expectations?

Remember, for the SP to rise to its full potential, the company needs to demonstrate that it can be profitable first, and secondly profitable for investors. Would be investors need to know that there is a sepsis problem and that Spectral has a solution. But they also need  to have an indication that management will know what to do to make a buck, vs spending a buck and, if that is the case, that they will not do everything they can to keep outside investors from reaping the benefits of the product's success.

Why expect the company to change its habits and its goals once the product is approved?

So informing the public has 2 significant advantages. Raising awareness and interest in the product and showing the company will always work hard to generate profit for its investors.



 

 
Bullboard Posts